HotSpot Therapeutics
PrivateLast Round
Series C
Nov 29, 2021
Total Funding Raised
$210M
Company Overview
HotSpot Therapeutics is a biotechnology company that specializes in allosteric drug discovery through a therapeutic platform that identifies hotspots and pathway treatments for cancer, metabolic, and rare diseases, utilizing data science to enhance drug discovery and improve patient access to effective treatments.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HotSpot Therapeutics Comps
Public and private peers based on sector, stage, and business model.
HotSpot Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 29, 2021 | ||||
| Series B | May 21, 2020 | ||||
| Series A | Jul 17, 2018 |
Key People
Founding team and executive leadership
HotSpot Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MRL Ventures Fund | Series B, Series C |
| MRLV | Series B |
| EQT Life Sciences | Series C |
| B Capital Group | Series C |
| Pivotal bioVenture Partners | Series C |
| Tekla Capital Management | Series B, Series C |
| Nan Fung Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Presented preclinical data at the 15th European Lupus Meeting.
- Mar 4, 2026
Launched interferon regulatory factor 5 (IRF5) program with preclinical data.
HotSpot Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HotSpot Therapeutics's valuation, stock price, and market status.